IP Library Granted Patent US 7,538,205
Granted Patent B2
US 7,538,205 · App. 11/359,554 · Granted May 26, 2009

Regulation of human prostasin-like serine protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,538,205
App. No.
11/359,554
Granted
May 26, 2009
Kind
B2
Abstract

Reagents which regulate human prostasin-like enzyme activity and reagents which bind to human prostasin-like enzyme gene products can be used to regulate human prostasin-like enzyme activity. Such regulation is particularly useful for treating metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.

Claims (3)

1. An isolated and purified protein comprising a first polypeptide segment comprising the amino acid sequence SEQ ID NO:2 or the amino acid sequence SEQ ID NO:6.

2. The protein of claim 1 further comprising a second polypeptide segment comprising an amino acid sequence which is not the amino acid sequence SEQ ID NO:2 or the amino acid sequence SEQ ID NO:6, wherein the second polypeptide segment is joined to the first polypeptide segment by means of a peptide bond.

3. An isolated and purified protein comprising an amino acid sequence which differs from the amino acid sequence SEQ ID NO:2 or the amino acid sequence SEQ ID NO:6 by between one and ten conservative amino acid substitutions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →